Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ulmer

Showing results (171-180 of 174) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 174 results.
Emerging Microbes & Infections|June 4, 2015
Rapidly produced SAM(®) vaccine against H7N9 influenza is immunogenic in miceArmin Hekele, Sylvie Bertholet, Jacob Archer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 6, 2022
A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical modelsGiulietta Maruggi, Corey P Mallett, Jason W Westerbeck, et al.
Plos One|April 27, 2018
Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvantYingxia Wen, Hung V Trinh, Christine E Linton, et al.
Plos One|November 16, 2012
HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodiesPaolo Monini, Aurelio Cafaro, Indresh K Srivastava, et al.
Pageof 18

Showing results (171-180 of 174) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 174 results.
Emerging Microbes & Infections|June 4, 2015
Rapidly produced SAM(®) vaccine against H7N9 influenza is immunogenic in miceArmin Hekele, Sylvie Bertholet, Jacob Archer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 6, 2022
A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical modelsGiulietta Maruggi, Corey P Mallett, Jason W Westerbeck, et al.
Plos One|April 27, 2018
Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvantYingxia Wen, Hung V Trinh, Christine E Linton, et al.
Plos One|November 16, 2012
HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodiesPaolo Monini, Aurelio Cafaro, Indresh K Srivastava, et al.
Pageof 18